- Carol Atkinson is an experienced philanthropist and volunteer.
- She is interested in the potential for focused ultrasound to improve treatment of psychiatric and neurological diseases through enhanced drug delivery to the brain and neuromodulation.
- The Council is a dedicated group that provides advice and assists with raising funds and building awareness.
The Foundation is pleased to welcome Carol Atkinson to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness.
Ms. Atkinson is a resident of New York City and Vero Beach, Florida. She is a philanthropist and volunteer with a long history of supporting education, healthcare, mental health, conservation, and vibrant communities. Today, she serves on the board of The Brain & Behavior Research Foundation, a global non-profit committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research. Having previously been a member of the Massachusetts General Hospital Council, Ms. Atkinson now serves on McLean Hospital’s National Council (focusing on mental illness). She earlier served on the board of City Harvest for 20 years.
An alumna of Ohio University and New York School of Design, Ms. Atkinson founded an interior design business and lived in Japan for eight years. She has two children and three grandchildren.
“Carol is an energetic, knowledgeable advocate for the Focused Ultrasound Foundation,” said Foundation Chairman Neal F. Kassell, MD. “She understands the potential of the technology, and we appreciate her efforts to raise awareness in her communities. We are thrilled to welcome Carol as the newest member of the Council.”
“I am delighted to join the Council and to help advance this life-changing therapy,” said Atkinson. “I am particularly interested in the potential for focused ultrasound to improve treatment of psychiatric and neurological diseases through enhanced drug delivery to the brain and neuromodulation.”